MDAs work by (1) improving viral spread in cancer cells through translational blocking of type I interferon (IFN) production and (2) enhancing cytokine-mediated polynucleation and bystander killing of surrounding, uninfected cancer cells. This evidence concerns the gene IFNA1 and cancer.